Company Filing History:
Years Active: 1995-1998
Title: Innovations of Katsumi Tachibana
Introduction
Katsumi Tachibana is a notable inventor based in Maebashi, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has advanced the detection of human G-CSF, a crucial component in medical diagnostics.
Latest Patents
Tachibana's latest patents include a method for selecting monoclonal antibodies for human G-CSF permitting. This invention relates to a high affinity monoclonal antibody for human G-CSF and an enzyme immunoassay using said antibody. The practice of this invention allows skilled professionals to obtain monoclonal antibodies that enable low-level detection of G-CSF in plasma, equal to or less than 0.5 pg/ml, without interference from human fluids. Another significant patent is for monoclonal antibodies and a method for the determination of human G-CSF. This invention allows for the measurement of trace amounts of human G-CSF in samples, such as body fluids from patients with hematological disorders, without interference. The measurable human G-CSF concentration in plasma can be as low as 0.5 pg/ml.
Career Highlights
Katsumi Tachibana is currently associated with Kirin-Amgen, Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in enhancing the accuracy of diagnostic tests, which can lead to better patient outcomes.
Collaborations
Tachibana has collaborated with notable colleagues, including Takanori Ichikawa and Tomoaki Kuwaki. Their combined expertise has contributed to the successful development of innovative solutions in their field.
Conclusion
Katsumi Tachibana's contributions to the field of biotechnology, particularly through his patents on monoclonal antibodies, have made a significant impact on medical diagnostics. His work continues to pave the way for advancements in the detection of critical biomarkers.